December

Scientists Find Potential Weapons for the Battle Against Antibiotic Resistance
Led by UNC School of Medicine’s Brian Conlon, PhD, research published in PLoS Biology shows how different bacterial strains interact to make each other more or less resistant to antibiotics.
National Clinical Trial Finds Certain Treatments for Blood Clots Not Effective
Stephan Moll, MD, professor of medicine and member of the UNC Hemophilia and Thrombosis Center, co-authored the results of a large-scale multicenter clinical trial focusing on catheter-directed thrombolysis and its effects.
Department of Pharmacy Earns $50,000 Award for Excellence in Medication Safety
The American Society of Hospital Pharmacists Foundation and the Cardinal Health Foundation honored a team of UNC pharmacist for their successful efforts to address rare and serious complications resulting from blood thinners.
Patients Notified of Privacy Incident at UNC Dermatology & Skin Cancer Center in Burlington, NC
Affecting Patients Seen by the “Burlington Dermatology Center” through September 2015.
NCI Grant to Help More Cancer Patients Become Tobacco-Free
A grant from the National Cancer Institute will help expand tobacco cessation programs for cancer patients at the N.C. Cancer Hospital. Adam O. Goldstein, MD, MPH, will lead the effort.
Biological Factors Don't Completely Explain Racial Disparities for ‘Good Prognosis’ Breast Cancer
The biological features of patients’ tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn’t explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.
Using Software, Researchers Predict Tumor Markers That Could Be Immune Targets
UNC Lineberger researchers led by Benjamin Vincent, MD, reported preliminary findings at the 59th ASH Annual Meeting in Atlanta that are an early step in the overall plan to use the software’s predictions to develop immune-based therapies for leukemia.
Immunotherapy Could Be Beneficial for Relapsed Acute Myeloid Leukemia
Researchers led by UNC Lineberger's Joshua Zeidner, MD, presented preliminary results from an ongoing phase II trial of the checkpoint inhibitor pembrolizumab and chemotherapy for relaposed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta.
UNC Scientists Discover Proteins Keeping Stem Cells in their Undifferentiated State
The lab of Jean Cook, PhD, found how a chain of proteins called an MCM complex could enable the fast cell-division that makes some forms of cancer so dangerous.
An Obsession to Serve
After 10 years as a US Army medic, Rick Cowan turned to the UNC School of Medicine, where he will graduate this year as a physician assistant.
Roper and Burriss named to '183 nonprofit hospital and health system CEOs to know 2017'
According to Becker's Hospital Review, "The men and women on this list lead some of the largest and most successful nonprofit healthcare organizations in the country. "
Chinese Cardiologists Visit UNC Medical Center as Part of AHA Collaboration
A delegation of medical professionals from across China toured Chapel Hill’s emergency department, cardiac catheterization lab and other facilities to learn about UNC’s STEMI system of care.
Share This: